Christopher Schaber
Chief Executive Officer chez SOLIGENIX, INC.
Fortune : 3 606 $ au 31/03/2024
Postes actifs de Christopher Schaber
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SOLIGENIX, INC. | Chief Executive Officer | 01/08/2006 | - |
| Chairman | 08/10/2009 | - | |
| President | 01/08/2006 | - | |
The National Organization for Rare Disorders, Inc.
 The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services The National Organization for Rare Disorders, Inc. operates as a non-profit federation of voluntary health organizations to help individuals with diseases and disorders. Its services are focused on the identification, treatment, and cure of disorders through programs of education, advocacy, research, and service. The company was founded in 1983 and is headquartered in Danbury, CT. | Corporate Officer/Principal | 17/08/2010 | - |
| American Society for Blood & Marrow Transplantation | Corporate Officer/Principal | 17/08/2010 | - |
| Alliance for Biosecurity | Director/Board Member | 01/10/2014 | - |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Director/Board Member | - | - |
| Chairman | 01/02/2019 | - |
Historique de carrière de Christopher Schaber
Anciens postes connus de Christopher Schaber
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| WINDTREE THERAPEUTICS, INC. | Chief Operating Officer | 01/01/1998 | 01/01/2006 |
| Discovery Laboratories, Inc. | Chief Operating Officer | 01/01/1998 | 01/01/2006 |
| Acute Therapeutics, Inc. | Compliance Officer | 01/01/1996 | 01/01/1998 |
| Founder | 01/01/1996 | 01/01/1998 | |
| General Counsel | 01/01/1996 | 01/01/1998 | |
| Ohmeda PPD, Inc. | General Counsel | 01/01/1994 | 01/01/1996 |
| ░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formation de Christopher Schaber
| McDaniel College | Undergraduate Degree |
| Union Institute & University | Doctorate Degree |
| Temple University School of Pharmacy | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 14 |
Opérationnelle
| Director/Board Member | 3 |
| Chief Operating Officer | 2 |
| Chairman | 2 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
BioSecurity Technologies, Inc.
 BioSecurity Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services BioSecurity Technologies, Inc. is engaged in acquiring intellectual properties for the purpose of developing commercial potential through licensure and sale. The firm specializes in the areas of homeland security, national defense, and technology applications. The company is headquartered in Richmond, VA. | Commercial Services |
| Acute Therapeutics, Inc. | |
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services The National Organization for Rare Disorders, Inc. operates as a non-profit federation of voluntary health organizations to help individuals with diseases and disorders. Its services are focused on the identification, treatment, and cure of disorders through programs of education, advocacy, research, and service. The company was founded in 1983 and is headquartered in Danbury, CT. | Health Services |
| American Society for Blood & Marrow Transplantation | |
| Ohmeda PPD, Inc. | |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
| Alliance for Biosecurity | |
| Discovery Laboratories, Inc. |
- Bourse
- Insiders
- Christopher Schaber
- Expérience
